SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Wolfgangrene's charts
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biotech Jim who wrote (1539)9/15/2015 9:36:05 PM
From: Biotech Jim1 Recommendation

Recommended By
The Ox

   of 3976
 
OK, I looked into AGTC a bit but did not do a thorough analysis. It is an interesting early stage gene therapy company with an apparently solid BIIB collaboration. For buying the stock, it depends if it is for a trade vs that of a longer term investement. Personally, I do not invest in gene therapy companies with the recent exception of JUNO and BLUE.

For a trade, it looks good as solid nascent company. For a longer term investment, to me it lacks longer term human data on longevity of the gene expression and safety of the AAV vectors/approach etc. I would need to follow the company more closely and carefully analyze all clinical and all safety data before I would jump in. There should be lots of opportunities to make an investment over the next 2-3 years.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News